Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In this issue:
› Safety issues with anti-HIV drugs
› Yellow Card reporting by doctors
› Safety issues in anaesthesia:
› Volatile anaesthetic agents and carboxyhaemoglobinaemia
› Reminder: Naloxone in opioid overdose
› Reminder: Hepatotoxicity with halothane
› Revised indications for co-amoxiclav (Augmentin)
› Lamotrigine (Lamictal): Increased risk of serious skin reactions in children
Current Problems in Pharmacovigilance May 1997 
